Search Results - "Schwartz Jr, S"

Refine Results
  1. 1

    EMT blockage strategies: Targeting Akt dependent mechanisms for breast cancer metastatic behaviour modulation by Rafael, D, Doktorovová, S, Florindo, H F, Gener, P, Abasolo, I, Schwartz, Jr, S, Videira, M A

    Published in Current gene therapy (01-01-2015)
    “…Epithelial Mesenchymal Transition (EMT) is an event where epithelial cells acquire mesenchymal-like phenotype. EMT can occur as a physiological phenomenon…”
    Get more information
    Journal Article
  2. 2

    Transforming pathways unleashed by a HDAC2 mutation in human cancer by Ropero, S, Ballestar, E, Alaminos, M, Arango, D, Schwartz, S, Esteller, M

    Published in Oncogene (26-06-2008)
    “…Although disruption of histone modification patterns is a common hallmark of human cancer, our knowledge of the mechanistic role of histone-modifying enzymes…”
    Get full text
    Journal Article
  3. 3

    Frameshift mutations at mononucleotide repeats in caspase-5 and other target genes in endometrial and gastrointestinal cancer of the microsatellite mutator phenotype by SCHWARTZ, S. JR, YAMAMOTO, H, NAVARRO, M, MAESTRO, M, REVENTOS, J, PERUCHO, M

    Published in Cancer research (Chicago, Ill.) (15-06-1999)
    “…The majority of tumors from hereditary nonpolyposis colorectal cancer families and a subset of unselected gastrointestinal and endometrial tumors exhibit a…”
    Get full text
    Journal Article
  4. 4

    Prognostic value of immunohistochemical expression of the c‐erbB‐2 oncoprotein in metastasic prostate cancer by Morote, Joan, de Torres, Inés, Caceres, Carme, Vallejo, Carlos, Schwartz, Simó, Reventos, Jaume

    Published in International journal of cancer (20-08-1999)
    “…It is well established that the activation of proto‐oncogenes could trigger uncontrolled cell growth and cancer development. Although this correlation has…”
    Get full text
    Journal Article
  5. 5

    KRAS and BRAF oncogenic mutations in MSS colorectal carcinoma progression by OLIVEIRA, C, VELHO, S, SCHWARTZ, S, CARNEIRO, F, SERUCA, R, MOUTINHO, C, FERREIRA, A, PRETO, A, DOMINGO, E, CAPELINHA, A. F, DUVAL, A, HAMELIN, R, MACHADOL, J. C

    Published in Oncogene (04-01-2007)
    “…In sporadic colorectal cancer (CRC), KRAS are alternative to BRAF mutations and occur, respectively, in 30 and 10% of cases. Few reports addressed the…”
    Get full text
    Journal Article
  6. 6

    BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing by Domingo, E, Laiho, P, Ollikainen, M, Pinto, M, Wang, L, French, A J, Westra, J, Frebourg, T, Espín, E, Armengol, M, Hamelin, R, Yamamoto, H, Hofstra, R M W, Seruca, R, Lindblom, A, Peltomäki, P, Thibodeau, S N, Aaltonen, L A, Schwartz, S

    Published in Journal of medical genetics (01-09-2004)
    “…Background: According to the international criteria for hereditary non-polyposis colorectal cancer (HNPCC) diagnostics, cancer patients with a family history…”
    Get full text
    Journal Article
  7. 7

    Serrated carcinomas form a subclass of colorectal cancer with distinct molecular basis by LAIHO, P, KOKKO, A, SCHWARTZ, S, ARANGO, D, MÄKINEN, M. J, AALTONEN, L. A, VANHARANTA, S, SALOVAARA, R, SAMMALKORPI, H, JARVINEN, H, MECKLIN, J.-P, KARTTUNEN, T. J, TUPPURAINEN, K, DAVALOS, V

    Published in Oncogene (11-01-2007)
    “…Serrated colorectal carcinomas (CRCs) are morphologically different from conventional CRCs and have been proposed to follow a distinct pathway of CRC…”
    Get full text
    Journal Article
  8. 8

    Gains of the relative genomic content of erbB-1 and erbB-2 in prostate carcinoma and their association with metastasis by Schwartz, Jr, S, Caceres, C, Morote, J, De Torres, I, Rodriguez-Vallejo, J M, Gonzalez, J, Reventos, J

    Published in International journal of oncology (01-02-1999)
    “…Prostate carcinoma (PC) is the second leading cause of cancer death in men in the western world. Although the role of oncogenes and growth factors in prostate…”
    Get more information
    Journal Article
  9. 9

    Somatic mutations in the DNA damage-response genes ATR and CHK1 in sporadic stomach tumors with microsatellite instability by MENOYO, Anna, ALAZZOUZI, Hafid, ESPIN, Eloi, ARMENGOL, Manel, YAMAMOTO, Hiroyuki, SCHWARTZ, Simo JR

    Published in Cancer research (Chicago, Ill.) (01-11-2001)
    “…Maintenance of genomic stability depends on the appropriate cellular responses to DNA damage and the integrity of the DNA repair systems. We analyzed stomach…”
    Get full text
    Journal Article
  10. 10

    Over‐expression of epidermal growth factor receptor and c‐ erbB2/neu but not of int‐2 genes in benign prostatic hyperplasia by means of semi‐quantitative PCR by Schwartz, Simó, Caceres, Carme, Morote, Joan, De Torres, Inés, M. Rodriguez‐Vallejo, José, Gonzalez, Jorge, Reventos, Jaume

    Published in International journal of cancer (18-05-1998)
    “…It is well established that activation of cellular genes may trigger uncontrolled cell growth and cancer development. Previous reports suggest that the…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    The C/C−13910 genotype of adult-type hypolactasia is associated with an increased risk of colorectal cancer in the Finnish population by Rasinperä, H, Forsblom, C, Enattah, N S, Halonen, P, Salo, K, Victorzon, M, Mecklin, J-P, Järvinen, H, Enholm, S, Sellick, G, Alazzouzi, H, Houlston, R, Robinson, J, Groop, P-H, Tomlinson, I, Schwartz, S, Aaltonen, L A, Järvelä, I

    Published in Gut (01-05-2005)
    “…Background and aims: The role of nutrition in the pathogenesis of colorectal cancer is not fully understood. Milk products are an essential part of human…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Bacterial cellulose hydrogel loaded with lipid nanoparticles for localized cancer treatment by Cacicedo, M.L., Islan, G.A., León, I.E., Álvarez, V.A., Chourpa, I., Allard-Vannier, E., García-Aranda, N., Díaz-Riascos, Z.V., Fernández, Y., Schwartz, S., Abasolo, I., Castro, G.R.

    Published in Colloids and surfaces, B, Biointerfaces (01-10-2018)
    “…[Display omitted] •Cationic state of the Dox in NLCs determined drug release and in vitro efficacy.•NLCs with cationic and neutral Dox were loaded into…”
    Get full text
    Journal Article
  16. 16

    The prevalence of PIK3CA mutations in gastric and colon cancer by Velho, Sérgia, Oliveira, Carla, Ferreira, Ana, Ferreira, António Carlos, Suriano, Gianpaolo, Schwartz, Simó, Duval, Alex, Carneiro, Fátima, Machado, José Carlos, Hamelin, Richard, Seruca, Raquel

    Published in European journal of cancer (1990) (01-07-2005)
    “…A wide variety of tumours show PIK3CA mutations leading to increased phosphatidylinositol-3 kinase ( PI3K) activity. We have determined the frequency of PIK3CA…”
    Get full text
    Journal Article
  17. 17
  18. 18

    BRAF mutations characterize colon but not gastric cancer with mismatch repair deficiency by OLIVEIRA, Carla, PINTO, Mafalda, SCHWARTZ, Simo JR, DUVAL, Alex, BRENNETOT, Caroline, DOMINGO, Enric, ESPIN, Eloi, ARMENGOL, Manel, YAMAMOTO, Hiroyuki, HAMELIN, Richard, SERUCA, Raquel

    Published in Oncogene (11-12-2003)
    “…Genes from the RAF family are Ras-regulated kinases involved in growth cellular responses. Recently, a V599E hotspot mutation within the BRAF gene was reported…”
    Get full text
    Journal Article
  19. 19

    Activated BRAF targets proximal colon tumors with mismatch repair deficiency and MLH1 inactivation by Domingo, Enric, Espín, Eloi, Armengol, Manel, Oliveira, Carla, Pinto, Mafalda, Duval, Alex, Brennetot, Caroline, Seruca, Raquel, Hamelin, Richard, Yamamoto, Hiroyuki, Schwartz Jr, Simó

    Published in Genes chromosomes & cancer (01-02-2004)
    “…BRAF, a serine/threonine kinase of the RAF family, is a downstream transducer of the RAS‐regulated MAPK pathway and signals upstream of MEK1/2 kinases…”
    Get full text
    Journal Article
  20. 20

    Concomitant RASSF1A hypermethylation and KRAS/BRAF mutations occur preferentially in MSI sporadic colorectal cancer by OLIVEIRA, Carla, VELHO, Sérgia, DOMINGO, Enric, PRETO, Ana, HOFSTRA, Robert M. W, HAMELIN, Richard, YAMAMOTO, Hiroyuki, SERUCA, Raquel, SCHWARTZ, Simo JR

    Published in Oncogene (17-11-2005)
    “…Methylation-associated inactivation of RASSF1A has frequently been observed in several human malignancies including sporadic colorectal and gastric cancer…”
    Get full text
    Journal Article